DexCom
DXCM
#830
Rank
C$41.78 B
Marketcap
C$112.05
Share price
-5.98%
Change (1 day)
45.60%
Change (1 year)

Operating Margin for DexCom (DXCM)

Operating Margin as of November 2026 (TTM): 23.34%

According to DexCom's latest financial reports and stock price the company's current Operating Margin is 23.34%. At the end of 2022 the company had an Operating Margin of 13.43%.

Operating Margin history for DexCom from 2006 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202213.43%89.1%
20217.10%-39.18%
202011.68%65.42%
20197.06%-157.57%
2018-12.26%81.29%
2017-6.76%-40.25%
2016-11.32%-20.86%
2015-14.30%66.25%
2014-8.60%-53.81%
2013-18.63%-66.66%
2012-55.86%-5%
2011-58.80%-36.86%
2010-93.13%-39.67%
2009-154.36%-71.25%
2008-536.97%-46.77%
2007-1,008.77%-55.62%
2006-2,273.03%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58% 48.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
18.02%-22.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
16.87%-27.72%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
7.17%-69.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
22.17%-5.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-5.85%-125.06%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-38.51%-265.00%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
23.24%-0.43%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.